Viridian Therapeutics, Inc. Appoints Stephen Mahoney as Chief Executive Officer
Company
Viridian Therapeutics
Description
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that Stephen Mahoney has been appointed the company’s President and Chief Executive Officer, and a member of the Board of Directors, effective immediately.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Rapport Therapeutics Appoints Chief Financial Officer (October 30, 2023)
- Cognito Therapeutics Appoints Christian Howell as Chief Commercial Officer (October 30, 2023)
- Calidi Biotherapeutics (CLDI) (CLDI) Announces Appointment of Andrew Jackson as Chief Financial Officer (October 30, 2023)
- cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer (November 1, 2023)
- Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer (November 1, 2023)
- Corcept Appoints Monica Tellado as President, Emerging Markets (November 1, 2023)
Who to call at Viridian Therapeutics, and when
A new leader at Viridian Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Viridian Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viridian Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viridian Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viridian Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Viridian Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.